FIBROBLAST GROWTH FACTOR BASIC FORM MEASUREMENT

Clinical trials for FIBROBLAST GROWTH FACTOR BASIC FORM MEASUREMENT explained in plain language.

Never miss a new study

Get alerted when new FIBROBLAST GROWTH FACTOR BASIC FORM MEASUREMENT trials appear

Sign up with your email to follow new studies for FIBROBLAST GROWTH FACTOR BASIC FORM MEASUREMENT, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.

Vår säkerhetsrekommendation!

Genom att skicka in godkänner du våra Användarvillkor

Not yet finished but already full! 1

New hope for older leukemia patients ineligible for harsh chemo

Disease control Ongoing

This early-stage study is testing the safety and best dose of a new drug, nintedanib, when combined with an existing drug, azacitidine. It is for older adults with a specific type of acute myeloid leukemia (AML) who are not candidates for or choose not to have intensive chemother…

Matched conditions: FIBROBLAST GROWTH FACTOR BASIC FORM MEASUREMENT

Phase: PHASE1 • Sponsor: Northwestern University • Aim: Disease control

Last updated Apr 03, 2026 14:43 UTC

FIBROBLAST GROWTH FACTOR BASIC FORM MEASUREMENT

Get alerted when new FIBROBLAST GROWTH FACTOR BASIC FORM MEASUREMENT trials appear

New hope for older leukemia patients ineligible for harsh chemo